Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Growth Hormone
Growth hormone (GH) in horses is a peptide hormone produced by the pituitary gland, playing a significant role in growth, metabolism, and overall development. It influences various physiological processes, including protein synthesis, cell growth, and the regulation of bone and muscle development. In equine physiology, GH impacts energy metabolism and can affect performance and recovery. Researchers study the secretion patterns, regulatory mechanisms, and effects of GH to understand its role in equine health and performance. This page compiles peer-reviewed research studies and scholarly articles that explore the biology, regulation, and implications of growth hormone in horses, providing insights into its effects on growth, metabolism, and athletic performance.
Seasonal variation and opioidergic regulation of growth hormone release in cyclic, ovariectomized, and pregnant pony mares. Modulation of reproductive functions is one of the multiple effects of growth hormone (GH). To investigate effects of reproductive functions on GH release in the horse, plasma GH concentrations in ovary-intact (n = 7) and ovariectomized (n = 8) mares during the anovulatory and breeding seasons and in pregnant mares (n = 6) at various stages of gestation were determined. To analyze an opioidergic regulation of GH release, repeated blood samples were taken over 3 h, and mares were injected with the opioid antagonist naloxone (0.5 mg/kg i.v.) or saline. GH was determined by RIA with an antiserum ...
The effects of equine somatotropin (eST) on follicular development and circulating plasma hormone profiles in cyclic mares treated during different stages of the estrous cycle. The effects of exogenous equine somatotropin (eST) administration on ovarian activity and plasma hormone levels were evaluated on horse and pony mares. The objectives of this study were to determine the effects of eST on follicular development and circulating concentrations of leutinizing hormone (LH), estradiol, progesterone, and insulin-like growth factor I (IGF-I) in cyclic horse and pony mares. Sixteen mares received daily injections (i.m.) of eST at a concentration of 25 micrograms/kg body weight on either Days 6 through 12 (Treatment A) or 13 through 19 (Treatment B) postovulation. In ad...
Endocrine and reproductive consequences of certain endotoxin-mediated diseases in farm mammals: a review. After giving an overview of the general pathology of endotoxin-mediated diseases, the authors summarise the endotoxin-induced endocrine changes and their clinical consequences, with particular regard to reproduction. The consequences of temporary activation of the cyclooxygenase-2 and lipoxygenase enzyme systems resulting in elevated release of various prostanoids are discussed in cyclic and pregnant ruminants, sows and mares. The clinical failures attributable to increased glucocorticoid secretion as well as the endotoxin-induced changes in thyroid function and in peripheral level of some oth...
Endocrinology of pregnancy: chorionic somatomammotropins and pregnancy-associated glycoproteins: review. The two main groups of placental proteins of ruminants are discussed in this paper: chorionic somatomammotropins (placental lactogens) and pregnancy-specific (-associated) proteins. Placental lactogens belong to the prolactin and growth hormone family. They stimulate mammogenesis, fetal growth and maternal metabolism. Pregnancy-specific proteins and pregnancy-associated glycoproteins belong to the aspartic proteinase family like pepsin, cathepsin D and E. These two groups of proteins are secreted in the maternal circulation by the binucleate cells after their migration to and fusion with the u...
Discrimination of mammalian growth hormones by peptide-mass mapping. Recognition by the legal authorities that growth hormones (GHs) may be abused to improve sporting performance and/or physique has led to the implementation of controls that make it an offence to produce, supply, possess or import and export GHs, with intent to supply, without the authority to do so. A method is described for the discriminatory analysis of human, equine, porcine and bovine GHs for forensic purposes. Peptide-mass mapping by matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry following tryptic digestion gave sequence coverages of 97.4%, 93.7...
Effects of two large doses of equine recombinant growth hormone on clinical, haematological and serum biochemical variables in adult horses. To evaluate the clinical, haematological, and serum biochemical effects of two large doses of recombinant equine growth hormone. Methods: Duplicated Latin square. Methods: Three Thoroughbred and three Standardbred mares aged between 12 and 17 years. Methods: Two horses were randomly assigned into one of three groups. On each of three successive days, each horse pair received one of two dosages of growth hormone or a saline placebo so that by the end of the experiment all three horse pairs had received both dosages and the saline placebo. Dose rates selected were 50 micrograms/kg, and 100 micro...
Immunocytochemical localization of prolactin and growth hormone in the equine pituitary. The ultrastructural and immunoreactive staining characteristics of cells containing prolactin (lactotropes) and growth hormone (GH; somatotropes) in the anterior pituitaries of gonadally intact pony mares were studied at the electron microscopic level. Lactotropes included two morphological subsets: Type I cells were larger and contained large, dense, polymorphic granules that were scattered throughout the cytoplasm; Type II cells were smaller and contained small, dense, polymorphic granules that were predominantly found in peripheral areas of the cytoplasm. Lactotropes constituted 5 to 16% of...
Characterization of prolactin- and growth hormone-binding proteins in milk and their diversity among species. The present study was undertaken to identify and characterize the diversity and species distribution of soluble prolactin binding-protein (PRL-BP) and growth hormone-binding protein (PRL-BP) in mammalian milk. We previously divided mammalian serum GH-BP into four main groups and identified a GH-BP with shared lactogenic/somatogenic properties in rabbit, horse, dog, pig and cat (Type III species). Here we describe PRL-BP in milk of Type III species and show it is relatively conserved within the group, having similar characteristics in terms of binding affinity for hGH (0.74-5.5 x 10(10) M(-1)),...
Feed intake, body weight, body condition score, musculation, and immunocompetence in aged mares given equine somatotropin. Sixteen 20- to 26-yr-old mares were given 0, 6.25, or 12.5 mg/d equine somatotropin (eST) to determine whether aged mares respond to ST with changes in feed intake, body weight, body condition score (based mostly on fat cover), or immunocompetence. Neither dry matter intake, body weight, nor body condition scores were altered during the 6 wk of eST injection. However, based on photographs taken to evaluate musculation before and after treatment (scores 0 to 4), mares given eST developed greater (P < .07) muscle definition (1.8 +/- .6 and 2.5 +/- .6 for 6.25 and 12.5 mg eST/d, respectively) ...
Effect of feeding and feed deprivation on plasma concentrations of prolactin, insulin, growth hormone, and metabolites in horses. Two experiments were conducted to determine 1) the prolactin response to different kinds of feedstuffs in stallions and 2) the effects of total feed deprivation on prolactin secretion in mares and its interaction with the prolactin response to feeding. Experiment 1 was performed with stallions as a 6 x 6 Latin square: A) no feed; B) pelleted feed fed to meet 82.5% of the horses' CP requirements; C) pelleted feed at 25% of the amount in B; D) pelleted feed as in B plus water ad libitum; E) cracked corn at the weight in B; and F) chopped alfalfa at the weight in B. The positive prolactin respons...
The effects of bovine somatotropin (bST) and porcine somatotropin (pST) on growth factor and metabolic variables in horses. Effects of exogenous pST and bST on metabolic and growth factor variables were examined in three studies with lighthorse mares (455 to 545 kg). In Study 1, eight mares received five s.c. injections of bST or pST (30 mg/d). In Studies 2 and 3, five mares received one s.c. injection of a prolonged release formulation designed to deliver 500 mg of bST (Study 2) or pST (Study 3) over 14 d. Blood samples were collected for several days before injection to establish baseline values, at frequent intervals during treatment, and for several days thereafter. In all studies, blood urea nitrogen concentra...
Feed deprivation of mares: plasma metabolite and hormonal concentrations and responses to exercise. Twelve light horse mares were fed a control diet that provided 100% of their maintenance protein and energy requirements for 7 d and were then either continued on the control diet or totally deprived of feed (with access to water) for 3 d . Plasma samples were drawn twice daily throughout the experiment, at 15-min intervals for 9 h beginning 45 h after feed removal, and at 10-min intervals around an exercise bout beginning 73 h after feed removal. Feed deprivation increased (P < or = .06) whole blood beta-hydroxybutyrate and plasma NEFA, urea N, L-lactate, and glucagon concentrations, decrease...
Dietary protein and(or) energy restriction in mares: plasma growth hormone, IGF-I, prolactin, cortisol, and thyroid hormone responses to feeding, glucose, and epinephrine. Sixteen light horse mares were fed diets of bermudagrass hay and a corn/cottonseed hull-based supplement formulated to contain either 100% (control) or 50% (restricted) of the protein and(or) energy requirements for maintenance in a 2 x 2 factorial arrangement of treatments. Plasma IGF-I, prolactin, cortisol, triiodothyronine, and thyroxine were monitored for 33 d. On the 27th d, frequent blood samples were drawn throughout the day for the measurement of growth hormone (GH), and on the 29th d, an epinephrine challenge and an i.v. glucose tolerance test (IVGTT) were performed in the morning and...
Growth hormone and prolactin concentrations in plasma of horses: sex differences and the effects of acute exercise and administration of growth hormone-releasing hormone. Three experiments were conducted to determine 1) the relationship between prolactin and growth hormone (GH) secretion in mares and the response to GH-releasing hormone (GHRH), 2) whether plasma GH and prolactin concentrations differed among mares, stallions, and geldings, and 3) whether sexual differences existed after administration of GHRH and acute exercise. In Exp. 1, 10-min blood samples were collected from 12 mares for 8 h, and GHRH (0, 45, 90, or 180 micrograms) was administered at 6 h. In Exp. 2, 15-min blood samples were collected for 4 h from 10 mares, stallions, and geldings. In Exp...
Sequence of a cDNA encoding horse growth hormone. A cDNA encoding horse growth hormone (ecGH) was isolated and sequenced. The coding sequence resembles a typical mammalian GH pre-protein and contains a 3' untranslated region of 101 nucleotides carrying two contiguous polyadenylation signals.
Changes in concentrations of hormones, metabolites, and amino acids in plasma of adult horses relative to overnight feed deprivation followed by a pellet-hay meal fed at noon. Experiment 1 was conducted to characterize the concentrations of prolactin, growth hormone (GH), cortisol, insulin, glucagon, glucose, nonesterified fatty acids (NEFA), urea N, and 10 indispensable amino acids in the plasma of mares (n = 8) and stallions (n = 8) during the last 4 h of a 19-h period of feed deprivation and for 8 h after a noon meal. Experiment 2 was similar to Exp. 1 except that only stallions (n = 8) were used, and they were either fed (n = 4) or not fed (n = 4) at noon in a 2 x 2 Latin square design conducted over two sampling days 7 d apart. In Exp. 1, increases (P < .01)...
Systemic bone growth factors in light breed mares and their foals. There is a high incidence of bony pathology in race horses. Thus, plasma GH, IGF-1, osteocalcin (OC), calcium (Ca) and inorganic phosphorus (P) concentrations were measured in 12 healthy Selle Français foals and their dams during the first five months after birth. Plasma IGF-1 and OC concentrations were higher in foals than in mares (336 +/- 25 vs 230 +/- 18 ng/ml, P < 0.05; 52.5 +/- 3.2 vs 4.9 +/- 0.1 ng/mg, P < 0.01, respectively). A significant positive linear relationship could be established between these two parameters in foals (IGF-1 = 19 + 0.619 OC; P < 0.05). Another strikin...
Development of homologous radioimmunoassays for equine growth hormone and equine prolactin and their application to the detection of circulating levels of hormone in horse plasma. Highly purified and well-characterised preparations of equine prolactin and growth hormone from equine pituitary glands were employed to set up highly sensitive and specific homologous radioimmunoassays (RIA) for the measurement of hormone in horse plasma. The limit of sensitivity of the GH RIA was 1.2 ng/ml with mean intra- and inter-assay coefficients of variation (CV) of 6.6 and 10%, respectively. The sensitivity of the equine prolactin (ePRL) RIA was 0.5 ng/ml with mean intra and inter-assay CV of 9.1 and 15.6%, respectively. Dose-response curves of a crude pituitary gland extract and plas...
Oxidation of methionine residues in equine growth hormone by Chloramine-T. 1. Reactivity of methionine residues towards Chloramine-T was studied in the equine growth hormone. 2. With a 20.0-fold molar excess of reagent over methionine, full oxidation of the four residues of the protein is achieved. 3. Methionine 4 is the most reactive group, followed by methionines 72 and 178--methionine 123 being the less reactive residue. 4. As judged by circular dichroism spectra and binding assays, protein conformation and binding capacity to specific receptors remains unchanged even after full oxidation of all four methionine residues. 5. Results agree with data previously obtai...
Growth hormone secretion in the horse: unusual pattern at birth and pulsatile secretion through to maturity. A heterologous radioimmunoassay was developed and validated for the measurement of horse GH in plasma. It utilized recombinant-derived bovine GH as the radiolabelled ligand, a guinea-pig anti-porcine GH serum as first antibody and pituitary-derived horse GH as standard. Cross-reactivities were high with all of the pituitary and recombinant-derived GH preparations tested (49-140%) and very low (< 0.3%) with horse FSH, LH and prolactin. A synthetic analogue of GH-releasing factor(1-29) stimulated the expected pattern of GH release in foals. Plasma GH concentrations in foals were low at birth (< ...
Immunocytochemical localization of some turkey pituitary hormones using antisera to human hormones. This study was conducted to determine the crossreactivity of antisera to human prolactin (PRL), adrenocorticotropic hormone (ACTH), and growth hormone (GH) to turkey pituicytes. In addition, crossreactivities of the above antisera and antiserum to turkey GH to pituicytes of turkey, cat, rabbit, horse, owl monkey, and human were evaluated. Results of the immunocytochemical localizations showed that with one exception antisera to human hormones were positive for each species tested. Turkey pituicytes failed to crossreact with antiserum to human GH. Likewise, antiserum to turkey GH failed to cros...
Growth hormone (GH) secretory pattern and GH response to GH-releasing factor (GRF) or thyrotropin-releasing hormone (TRH) in newborn foals. The present study was undertaken to assess GH secretory profiles in 12 light-breed foals and their dams during forty days after delivery, and the possible influence of GRF and TRH on plasma GH concentrations in these newborn foals. GH secretory pattern was pulsatile in one day- as well as in forty days-old foals. The number of secretory spikes (10 per 24 h) did not vary between days 1 and 40. In the same times, GH secretion did not show any circadian rhythm either in foals or in their dams. Mean daily plasma concentrations (measured through blood samples collected every 20 min for 24 h) were l...
Growth hormone in mares and stallions: pulsatile secretion, response to growth hormone-releasing hormone, and effects of exercise, sexual stimulation, and pharmacological agents. Short-term patterns of growth hormone (GH) secretion and factors affecting it were studied in mares and stallions. In Exp. 1, hourly blood samples were collected from three mares and three stallions in summer and winter. Although GH concentrations varied in a pulsatile manner in all horses, there was no effect of sex or season (P greater than .1) on plasma GH concentrations and no indication of a diurnal pattern of GH secretion. In Exp. 2, 10-min blood samples were drawn for 8 h from 12 mares; after 6 h, porcine GH-releasing hormone (GHRH) was administered i.v. at 0, 45, 90, or 180 micrograms/...
Identification and partial purification of serum growth hormone binding protein in domestic animal species. The chemical nature and variations in serum concentrations of growth hormone binding protein (GHBP) from humans, rabbits, and rodents have been reported. To date little is known about the GHBP of domestic animals. Therefore, we initiated these studies to determine whether a serum GHBP was present in domestic animals and to purify the binding protein (BP) from serum of selected species. Using a dextran-coated charcoal separation assay, specific growth hormone (GH) binding was demonstrated in ovine, bovine, chicken, human, goose, porcine, and equine serum (listed in sequence from lowest to highe...
Cloning the cDNA for horse growth hormone and expression in Escherichia coli. A 514 bp cDNA transcript coding for 78% of horse (Equus caballus.) GH has been cloned and sequenced. The deduced amino acid sequence corresponded precisely to that previously obtained by protein sequencing and, in addition, provided new sequence information for the signal peptide. The missing 3' fragment of the cDNA was reconstructed using synthetic oligonucleotides and site-specific directed mutagenesis. The complete cDNA sequence was then inserted into an expression vector (PIN-III-lppp-5) which utilizes a bacterial signal peptide to secrete the expressed product into the periplasmic space o...
Partial purification and characterization of rhinoceros gonadotropins, growth hormone, and prolactin: comparison with the horse and sheep. The rhinoceros is an endangered species related to the horse family. Little is known of its reproductive endocrinology. The objectives of this study were to partially purify rhinoceros pituitary hormones, determine which assays could be used for their assessment, and to ascertain whether rhinoceros LH possesses the intrinsic FSH activity of equine LH. A single pituitary each from a White (1.3 g) and a Black (1.2 g) Rhinoceros was homogenized and extracted (pH 9.5), then subjected to pH and salt fractionation, and ion-exchange chromatography (DEAE and Sephadex SP-C50) to yield partially purifie...
Equine growth hormone. Detection of immunoreactive sequences using poly- and monoclonal antibodies. The immunochemical behavior of several fragments of equine growth hormone (eGH) was examined using competitive binding assays with antibodies (Abs) to eGH obtained from different sources. Antigenicity was detected within the sequences 5-72 and 73-123 by rabbit Abs to eGH and by three mouse monoclonal antibodies (MAbs) produced by using bovine growth hormone as immunogen, but showing heteroclitic properties towards eGH. The polyclonal Abs to eGH also recognized as immunoreactive two smaller peptides corresponding to the amino acid residues 52-72 and 110-123. By contrast, the heteroclitic Abs to...
Conformational comparison in the growth hormone family. 1. The method of Kubota et al. [Biochim. biophys. Acta 701, 242-252 (1982)] was applied to several members of the growth hormone family in order to examine their conformational homology. 2. The method neither detects differences between rat, cow, sheep, horse and alpaca hormones, nor between monkey and human hormones. 3. Lack of homology between primate and non-primate growth hormones was found in segments 42-49 and 184-191. The first fragment could be linked to species-specificity.
Primary structure of equine pituitary prolactin. Equine prolactin was determined to be a single chain protein of 199 amino acid containing two tryptophan and six cysteine residues, as found in other mammalian prolactins. The primary sequence of equine prolactin was obtained by automated Edman analyses of S-carboxymethylated protein and proteolytic fragments of modified protein. Of the known prolactin sequences, equine prolactin shows closest homology with porcine (93%) and fin whale (87-91%) prolactins. Genetic mutations have produced changes in 17 of 199 residues of equine prolactin relative to its putative ancestral precursor. Since equine...
